Dercum's Disease
A rare disorder of multiple painful subcutaneous lipomas — misdiagnosed as obesity, fibromyalgia, or 'stress' for years on average. The sister condition to Madelung's Disease in the adipose-disorder family.
What we mean when we say Dercum's.
Dercum's disease — also called adiposis dolorosa — is a rare disorder characterized by multiple painful lipomatous growths in subcutaneous tissue, typically across the trunk, upper arms, thighs, and forearms. Onset is most common between 35 and 50, and the condition affects women far more often than men.
Unlike ordinary adipose tissue, Dercum's lipomas are painful, do not respond predictably to weight loss, and tend to progress over time. The literature distinguishes four subtypes — juxta-articular, diffuse, nodular, and mixed — distinctions that carry real implications for surgical and non-surgical management.
Dercum's shares tissue-level pathology with Madelung's Disease and lipedema, and often overlaps with metabolic dysfunction, sleep-disordered breathing, and connective-tissue differences. The integrated picture is rarely assembled in routine care.
The pattern we see in Dercum's cases.
- 01Under-recognized outside a handful of specialists. Most primary-care and general-surgical clinicians dismiss it as obesity-related, delaying accurate diagnosis by an average of many years.
- 02Pain management is complex. Standard analgesics are often inadequate, and the literature on effective approaches — low-dose naltrexone, IV lidocaine, targeted surgical debulking, deoxycholic acid — is scattered across specialties.
- 03Subtype distinctions matter but are inconsistently applied. A diffuse-type case has different surgical considerations than a nodular-type case; non-expert clinicians rarely apply this framework.
- 04The specialist universe is small. A few adipose-disorder specialists see meaningful volume; most patients are told to 'live with it' by clinicians who have never treated the condition.
The Ternary Signal Library for Dercum's.
Our Signal Library codifies the specific patterns that matter in Dercum's — labs, genetic variants, imaging findings, symptom clusters, and comorbidity combinations. Your case is mapped against these signals in Stage 4 of the workflow; each present signal is identified and prioritized for your presentation.
- —Subtype classification — juxta-articular / diffuse / nodular / mixed
- —Anatomic mapping — trunk, arms, thighs, forearms
- —Pain character — burning / aching / pressure-sensitive
- —Pain triggers — pressure, temperature, menstrual cycle
- —Functional impact — mobility, sleep, daily activities
- —Inflammatory markers — CRP, ESR
- —Thyroid panel — TSH, free T4, antibodies
- —Metabolic panel — fasting insulin, A1c, lipids
- —Hormone panel — estrogen, progesterone, cortisol
- —Vitamin D, B12, magnesium — correctable deficiencies
- —Targeted ultrasound of painful regions
- —Whole-body MRI when distribution is ambiguous
- —DEXA body composition if metabolic overlap suspected
- —Connective-tissue assessment (Beighton, skin findings)
- —Sleep apnea / disordered breathing
- —Hypermobility / connective-tissue features
- —Venous or lymphatic dysfunction
- —Autoimmune or inflammatory conditions
- —Prior liposuction and recurrence history
The Ternary Health approach to Dercum's.
Review distribution, subtype, pain pattern, and associated findings against published Dercum's frameworks — then classify where the data supports it.
Integrate metabolic workup, sleep studies, connective-tissue assessment, and imaging into a single view rather than a stack of isolated consults.
Map pain-management options — medication, procedural, lifestyle — with evidence grading per strategy, so the trade-offs are visible, not hidden.
Surgical and non-surgical decision support — including identification of the short list of global specialists with Dercum's-specific experience.
How a Dercum's case moves through our workflow.
Our nine-stage workflow is the same for every engagement. What changes per condition is the content at each stage — the records we pull, the signals we apply, the specialists we map, the pathways we evaluate. Below, how your case specifically would move through each stage.
What you receive.
- —A written case synthesis with subtype classification
- —Integrated view of pain pattern, metabolic status, and co-occurring features
- —Evidence-graded pain-management framework
- —Surgical and non-surgical decision support
- —Specialist identification with Dercum's-specific experience
- —A written action plan and follow-up support as you implement it
What prospective Dercum's clients ask most.
Three ways to engage Ternary on Dercum's.
From a free starting point to a full personalized action plan — three tiers, one methodology, all tailored to Dercum's.
Free Brief
A 3–5 page personalized starting point on your condition. Most relevant labs, specialist categories, first decisions worth pursuing. No charge.
Generated instantly, no charge.
Get a free Brief→Launchpad
A research-based preparedness guide. Current literature, realistic prognosis, test and treatment categories worth exploring, and a checklist of what you might consider to better manage and understand your condition.
Delivered in 3–5 business days
Start a Launchpad→Precision Deep Dive
A vigorously researched and highly personalized action plan: the specialists and centers of excellence worth considering, evidence-graded options, and a prioritized set of questions to raise — all curated for your specific condition and lifestyle, for you and your physicians to weigh together. The plan includes 30 days of follow-up support and tailored insights into how best to navigate your situation now and in the future.
September 2026 cohort
Apply for a Deep Dive→See exactly what you receive.
A composite sample illustrating the structure and depth of every Ternary Health Precision Deep Dive. Same universal 17-section format used for Dercum's — drawn from four research-validated patient profiles across four conditions.
Every Ternary engagement produces a report with the same architecture: client profile, applied methodology, signal analysis, lab and genetic findings, imaging synthesis, disease model, intervention prioritization, specialist pathway, staged medical therapy, 90-day roadmap, and monitoring cadence. The composite shows you exactly how that architecture renders.
Ready for a case review?
Applications for the September 2026 cohort are open now and reviewed in the order received. Not ready? A free Ternary Brief on Dercum's is generated instantly, no charge.